Pfizer reported a 9% drop in fourth-quarter revenue, hurt by intense competition for its pain treatment Lyrica that lost patent protection last year. Read more...
Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties






